Vivancos Martinez, Marta,Alvarez Fernandez, Lisardo,Velada Calzada, Jose
申请号：
AU2016378482
公开号：
AU2016378482A1
申请日:
2016.12.22
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to a pharmaceutical composition comprising amorphous lenalidomide, or a pharmaceutically acceptable salt thereof, with a synthetic antioxidant and one or more pharmaceutically acceptable excipients. The invention further relates to the process to manufacture such a compositions and the use of said composition as a medicament, particularly in the treatment of in the treatment of multiple myeloma and myelodyplastic syndromes.
